Oppenheimer Asset Management Inc. Has $838,000 Holdings in Humana Inc. (NYSE:HUM)

Oppenheimer Asset Management Inc. lessened its holdings in shares of Humana Inc. (NYSE:HUM) by 83.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 3,302 shares of the insurance provider’s stock after selling 16,345 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Humana were worth $838,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Mn Services Vermogensbeheer B.V. raised its stake in Humana by 1.7% during the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 48,012 shares of the insurance provider’s stock worth $12,181,000 after buying an additional 800 shares during the period. New York Life Investment Management LLC raised its stake in Humana by 1.1% during the 4th quarter. New York Life Investment Management LLC now owns 18,049 shares of the insurance provider’s stock worth $4,579,000 after buying an additional 205 shares during the period. Oregon Public Employees Retirement Fund raised its stake in Humana by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,316 shares of the insurance provider’s stock worth $2,617,000 after buying an additional 62 shares during the period. Horizon Advisory Services Inc. bought a new position in Humana during the 4th quarter worth about $297,000. Finally, Capital Advisors Ltd. LLC increased its holdings in Humana by 26.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 43 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Up 0.8 %

Humana stock opened at $263.74 on Wednesday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $31.82 billion, a P/E ratio of 26.51, a PEG ratio of 2.05 and a beta of 0.57. The stock has a 50-day simple moving average of $271.40 and a 200 day simple moving average of $285.08.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Piper Sandler increased their target price on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Morgan Stanley lowered their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. StockNews.com cut Humana from a “buy” rating to a “hold” rating in a report on Wednesday. Truist Financial increased their target price on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Finally, Barclays increased their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Twenty analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Humana currently has a consensus rating of “Hold” and an average price target of $285.68.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.